AURORA: A single arm, multicentre, phase II clinical trial of atezolizumab immunotherapy for advanced squamous cell carcinoma of the bladder and urinary tract. Sasanlimab in combination with bacillus ...
Bladder cancer affects approximately 83,000 Americans each year, yet remains one of the most overlooked forms of cancer despite having excellent survival rates when caught early. This disconnect ...
Maintenance zanzalintinib with oral etoposide following high-dose chemotherapy in patients with relapsed metastatic germ-cell tumor (GCT). Circulating tumor (ct)DNA-guided adjuvant atezolizumab (atezo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results